Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Novavax Inc. sell JPMorgan Chase & Co.

Start price
€10.93
12.08.24 / 50%
Target price
€8.23
12.08.25
Performance (%)
-34.15%
End price
€7.20
13.08.25
Summary
This prediction ended on 13.08.25 with a price of €7.20. JPMorgan_Chase___Co_ correctly predicted massive losses of -34.15% for Novavax Inc.. JPMorgan_Chase___Co_ has a follow-up prediction for Novavax Inc. where he still thinks Novavax Inc. is a Sell. JPMorgan_Chase___Co_ has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y
Novavax Inc. -18.233% -18.233% -37.885%
iShares Core DAX® -0.099% 1.027% 31.262%
iShares Nasdaq 100 -1.085% 2.134% 14.536%
iShares Nikkei 225® -0.835% 8.556% 5.546%
iShares S&P 500 0.099% 2.881% 11.163%

Comments by JPMorgan_Chase___Co_ for this prediction

In the thread Novavax Inc. diskutieren
Prediction Sell
Perf. (%) -34.15%
Target price 8.227
Change
Ends at 12.08.25

Novavax, Inc. (NASDAQ: NVAX) had its price target raised by analysts at JPMorgan Chase & Co. from $8.00 to $9.00. They now have an "underweight" rating on the stock.
Ratings data for NVAX provided by MarketBeat

In the thread Trading Novavax Inc.
Prediction Sell
Perf. (%) -34.15%
Target price 8.227
Change
Ends at 12.08.25

Die von JPMorgan_Chase___Co_ gewählte maximale Laufzeit wurde überschritten

Current prediction by JPMorgan_Chase___Co_ for Novavax Inc.

Novavax Inc.

Start price
Target price
Perf. (%)
€5.45
09.05.25
€6.24
09.05.26
22.73%
22.08.25